(R)-N,N-diisopropyl-3-(2-benzyloxy-5-formylphenyl)-3-phenylpropanamine | 214601-54-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (R)-N,N-diisopropyl-3-(2-benzyloxy-5-formylphenyl)-3-phenylpropanamine
• 英文别名: 4-(benzyloxy)-3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]benzaldehyde；(R)-4-(benzyloxy)-3-(3-(diisopropylamino)-1-phenylpropyl)benzaldehyde；(R)-[4-benzyloxy-3-(3-diisopropylamino-1-phenyl-propyl)-phenyl]-methanal；3-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-phenylmethoxybenzaldehyde
• CAS: 214601-54-4
• 化学式: C₂₉H₃₅NO₂
• 分子量: 429.602
• InChiKey: PSNQHGJVGCUGBC-HHHXNRCGSA-N

物化性质

• 沸点：
  567.3±50.0 °C(Predicted)
• 密度：
  1.058±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.6
• 重原子数：
  32
• 可旋转键数：
  11
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.34
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (R)-N,N-diisopropyl-3-(2-benzyloxy-5-formylphenyl)-3-phenylpropanamine 在 盐酸 、 sodium tetrahydroborate 、 sodium carbonate 、 sodium hydroxide 作用下， 以 二氯甲烷 、 水 为溶剂， 生成 (R)-5-羟甲基托特罗定
  参考文献：
  名称：

  [EN] A PROCESS FOR PREPARING FESOTERODINE
  [FR] PROCÉDÉ DE PRÉPARATION DE FÉSOTÉRODINE

  摘要：

  本发明涉及一种改进的制备Fesoterodine及其药用盐的方法。本发明特别涉及一种制备Fesoterodine及其药用盐的方法，其中涉及使用和制备R(+)苄基托特罗定和R(+)-[4-苄氧基-3-(3-二异丙基氨基-1-苯基丙基)-苯基]-甲醇富马酸盐。

  公开号：

  WO2012137047A1
• 作为产物：
  描述：

  (R)-托特罗定L-酒石酸盐 在 ammonium cerium (IV) nitrate 、 sodium carbonate 、 sodium hydroxide 作用下， 以 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 17.58h， 生成 (R)-N,N-diisopropyl-3-(2-benzyloxy-5-formylphenyl)-3-phenylpropanamine
  参考文献：
  名称：

  Ligand–Phospholipid Conjugation: A Versatile Strategy for Developing Long-Acting Ligands That Bind to Membrane Proteins by Restricting the Subcellular Localization of the Ligand

  摘要：

  We hypothesized that if drug localization can be restricted to a particular subcellular domain where their target proteins reside, the drugs could bind to their target proteins without being metabolized and/or excreted, which would significantly extend the half-life of the corresponding drug target complex. Thus, we designed ligand phospholipid conjugates in which the ligand is conjugated with a phospholipid through a polyethylene glycol linker to restrict the subcellular localization of the ligand in the vicinity of the lipid bilayer. Here, we present the design, synthesis, pharmacological activity, and binding mode analysis of ligand phospholipid conjugates with muscarinic acetylcholine receptors as the target proteins. These results demonstrate that ligand phospholipid conjugation can be a versatile strategy for developing long-acting ligands that bind to membrane proteins in drug discovery.

  DOI：

  10.1021/acs.jmedchem.8b00041

文献信息

• Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine
  申请人：LEK Pharmaceuticals d.d.

  公开号：EP2364966A1

  公开（公告）日：2011-09-14

  A process is described for the preparation of 3-(5-formyl-2-hydroxyphenyl)-3-phenylpropylamine derivatives, intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.

  描述了一种制备3-(5-甲酰基-2-羟基苯基)-3-苯基丙胺衍生物的过程，这些中间体可用于制备用于治疗尿失禁的药物，特别是用于2-(3-(二异丙基氨基)-1-苯基丙基)-4-(羟甲基)苯酚及其前药的制备。
• [EN] SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES<br/>[FR] SYNTHÈSE COURTE DE TOLTÉROPINE, INTERMÉDIAIRES ET MÉTABOLITES
  申请人：LEK PHARMACEUTICALS

  公开号：WO2011110556A1

  公开（公告）日：2011-09-15

  A process is described for the preparation of intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)- 1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.

  描述了一种用于制备中间体的过程，这些中间体可用于制备尿失禁治疗药物，特别是用于2-(3-(二异丙基氨基)-1-苯基丙基)-4-(羟甲基)苯酚及其前药的制备。
• [EN] DESFESOTERODINE SALTS<br/>[FR] SELS DE DESFÉSOTÉRODINE
  申请人：RATIOPHARM GMBH

  公开号：WO2013188829A1

  公开（公告）日：2013-12-19

  The invention relates to substantially pure Desfesoterodine salts, Desfesoterodine salts, solid state forms thereof and pharmaceutical compositions comprising one or more of the Desfesoterodine salts and/or solid state forms thereof.

  这项发明涉及基本纯度的Desfesoterodine盐、Desfesoterodine盐、其固态形式以及包含一种或多种Desfesoterodine盐和/或其固态形式的药物组合物。
• Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
  申请人：Pharmacia AB

  公开号：US06313132B1

  公开（公告）日：2001-11-06

  The invention relates to novel compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and Ar are as defined in claim 1, their salts with physiologically acceptable acids and, when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers. The compounds have anticholinergic activity, and the invention also relates to the compounds of Formula (I), the use of the compounds of Formula (I) for preparing anticholinergic drugs, the use of the compounds of Formula (I) for treating urinary tract incontinence, and methods for preparing the compounds of Formula (I).

  该发明涉及以下式（I）的新化合物，其中R1、R2、R3、R4、R5、R6、R7和Ar如权利要求1中所定义，它们与生理学上可接受的酸盐形式，当该化合物可以是光学异构体形式时，包括消旋混合物和各个对映体。这些化合物具有抗胆碱能活性，该发明还涉及式（I）的化合物，使用式（I）的化合物制备抗胆碱药物，使用式（I）的化合物治疗尿道失禁，以及制备式（I）的化合物的方法。
• SHORT SYNTHESIS OF TOLTERODINE, INTERMEDIATES AND METABOLITES
  申请人：Sterk Damjan

  公开号：US20130197082A1

  公开（公告）日：2013-08-01

  A process is described for the preparation of intermediates which can be used for preparation of agents for urinary incontinence therapy, specifically to 2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol and its prodrugs.

  描述了一种制备中间体的过程，该中间体可用于制备尿失禁治疗剂，特别是用于制备2-(3-(二异丙基氨基)-1-苯基丙基)-4-(羟甲基)苯酚及其前药。